文献速递胸部CT

ScreenLungNet:基于单次低剂量CT筛查的肺癌风险个体化长期预测

ScreenLungNet: Personalized Long-Term Prediction of Lung Cancer Risk from a Single Low-Dose CT Screening.
PubMed 文献 · Radiology · 2025-01-01

本研究利用温岭2019-2020筛查队列和浙江省肿瘤医院临床CT数据,开发了基于低剂量CT的3年肺癌风险预测模型ScreenLungNet,整合多发结节特征与全局肺特征,在温岭2021内部测试集和NLST外部测试集上AUC达0.93-0.94,优于仅基于结节的模型,并能在筛查阴性者中预测风险。

要点

  • ScreenLungNet整合多发结节与全局肺特征预测3年肺癌风险,AUC 0.93-0.94,优于仅结节模型(P<.001)。
  • NLST外部测试集AUC 0.93,敏感度84.9%、特异度95.2%、NPV 99.3%。
  • NLST基线阴性亚组AUC 0.87,敏感度72.1%、特异度97.5%,可用于筛查阴性者风险预测。

核心结论

  • 整合多发结节与全局肺特征的模型在长期肺癌风险预测上优于仅基于结节的模型,并能在筛查阴性参与者中实现风险预测。

研究设计与样本

  • 回顾性研究,使用温岭2019-2020筛查队列19869名参与者(平均年龄60.93岁±6.30,男13123例,肺癌343例)和浙江省肿瘤医院2017-2023年临床CT数据1802例患者训练模型,在温岭2021队列(n=9932)进行内部独立测试、NLST队列(n=14966)进行外部测试。

诊断标准与关键数值

  • ScreenLungNet的3年肺癌风险预测AUC范围为0.93-0.94(P<.001);NLST队列AUC 0.93(95%CI:0.92,0.94)、准确率94.8%、敏感度84.9%、特异度95.2%、PPV 44.0%、NPV 99.3%(所有P<.02);NLST基线阴性亚组AUC 0.87、准确率97.0%、敏感度72.1%、特异度97.5%。

临床应用与阅片要点

  • 原文结论提示该模型可用于筛查阴性参与者的长期风险预测,但原文未给出具体阅片或报告操作建议。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Lung cancer screening with low-dose CT (LDCT) primarily relies on identifying nodules, disregarding global lung features, and may underestimate long-term cancer risk. Purpose To determine whether considering global lung features alongside nodules could improve long-term lung cancer risk prediction. Materials and Methods In this retrospective study, ScreenLungNet, a 3-year lung cancer risk prediction model, was developed using LDCT data from the Wenling 2019-2020 screening cohort (Zhejiang Province, China) and clinical CT data from Zhejiang Cancer Hospital (2017-2023). Features from multiple nodules derived from malignancy scores and global lung features were extracted via a vision transformer and integrated into the model. To assess the added value of global lung features, single-nodule (based on the highest-risk nodule), multiple-nodule (based on multiple-nodule features), and global (based on global lung features) lung models were constructed for comparison. Model performance was assessed with the area under the receiver operating characteristic curve (AUC), accuracy, specificity, sensitivity, positive predictive value (PPV), and negative predictive value (NPV). Results Model training included 19 869 participants from the Wenling 2019-2020 screening cohort (mean age, 60.93 years ± 6.30 [SD]; 13 123 male; 343 patients with lung cancer) and 1802 patients from Zhejiang Cancer Hospital. Finally, independent internal and external tests were conducted on the Wenling 2021 (n = 9932) and National Lung Screening Trial (NLST) (n = 14 966) cohorts, respectively. ScreenLungNet outperformed other models for 3-year lung cancer risk prediction (AUC range, 0.93-0.94; P < .001). In the NLST cohort, ScreenLungNet performed well (AUC, 0.93 [95% CI: 0.92, 0.94]; accuracy, 94.8%; sensitivity, 84.9%; specificity, 95.2%; PPV, 44.0%; NPV, 99.3%; all P < .02). Its performance remained strong in the NLST baseline-negative subset (AUC, 0.87; accuracy, 97.0%; sensitivity, 72.1%; specificity, 97.5%). Conclusion A model integrating multiple nodules and global lung features outperformed nodule-only models for long-term lung cancer risk prediction and enabled risk prediction in screening-negative participants. © The Author(s) 2025. Published by the Radiological Society of North America under a CC BY 4.0 license. Supplemental material is available for this article. See also the editorial by Staziaki in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Lin C, Tan W, Zhou Z, et al. ScreenLungNet: Personalized Long-Term Prediction of Lung Cancer Risk from a Single Low-Dose CT Screening. Radiology. 2025. PMID: 41117646. doi:10.1148/radiol.251310

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。